8-K: Supernus Pharmaceuticals to Announce First Quarter 2025 Financial Results on May 6, 2025

Supernus Pharmaceuticals will release its Q1 2025 financial results after market close on May 6, 2025, followed by a conference call and webcast.

Summary

• Supernus Pharmaceuticals, Inc. is set to announce its financial and business results for the first quarter of 2025.
• The announcement will be made after the market closes on Tuesday, May 6, 2025.
• Following the announcement, the company will host a conference call and webcast on the same day at 4:30 p.m. E.T.
• The conference call will be hosted by Jack Khattar, President and CEO, and Tim Dec, Senior Vice President and CFO.
• The call will include prepared remarks, a discussion of business results, and a Q&A session.
• A live webcast will be accessible on the company's Investor Relations website, and a replay will be available for 60 days.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it is a routine announcement of an upcoming earnings release and conference call.

Positives

• Supernus Pharmaceuticals is providing transparency by announcing its Q1 2025 financial results and hosting a conference call.
• The availability of a webcast and replay allows for broader access to the company's discussion of its results.

Future Outlook

The company will provide insights into its business and financial performance during the conference call and webcast.

Management Comments

• Jack Khattar, President and CEO, and Tim Dec, Senior Vice President and CFO, will host the conference call.

Industry Context

This announcement is a standard practice for publicly traded companies to communicate their financial performance to investors and the market.

Stakeholder Impact

• Shareholders will be informed about the company's financial performance.
• Analysts and investors will have the opportunity to ask questions during the conference call.

Next Steps

• Supernus Pharmaceuticals will report its Q1 2025 financial results.
• The company will host a conference call and webcast to discuss the results.

Key Dates

Keywords

Supernus Pharmaceuticals, Financial Results, Conference Call, Webcast, Q1 2025, Earnings, SUPN